John T. Schwieters
Known title: DirectorCIK: 0001187930
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Danaher Expands AI Integration in Scientific Research. Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.
Transaction History
| VLTO | ▲ Buy | Grant | 1,009 | $0 | 7/15/2026 | View on chart |
| VLTO | ▲ Buy | Grant | 818 | $0 | 7/15/2025 | View on chart |
| DHR | ▲ Buy | Option Exercise | 3,928 | $233K | 7/15/2025 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 1,209 | $233K | 7/15/2025 | View on chart |
| DHR | ▲ Buy | Grant | 577 | $0 | 5/15/2025 | View on chart |
| DHR | ▲ Buy | Option Exercise | 3,289 | $173K | 7/15/2024 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 703 | $173K | 7/15/2024 | View on chart |
| VLTO | ▲ Buy | Grant | 842 | $0 | 7/15/2024 | View on chart |
| DHR | ▲ Buy | Grant | 390 | $0 | 5/15/2024 | View on chart |
| VLTO | ▲ Buy | Grant | 711 | $0 | 11/15/2023 | View on chart |
| DHR | ▲ Buy | Option Exercise | 3,490 | $177K | 7/28/2023 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 682 | $177K | 7/28/2023 | View on chart |
| DHR | ▲ Buy | Grant | 430 | $0 | 5/15/2023 | View on chart |
| DHR | ▲ Buy | Option Exercise | 4,548 | $176K | 7/13/2022 | View on chart |
| DHR | ▲ Buy | Grant | 372 | $0 | 5/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Veralto Sets Date for Q3 2026 Earnings Call
Veralto has announced the schedule for its third-quarter 2026 earnings call, providing investors with a specific date to review upcoming financial results. This announcement is a standard corporate disclosure that helps the market prepare for the next major update on the company's performance. The stock is currently trading near its 52-week high, reflecting strong recent momentum ahead of this scheduled event.
Veralto Sets Date for Q3 2026 Earnings Call. Veralto has announced the schedule for its third-quarter 2026 earnings call, providing investors with a specific date to review upcoming financial results. This announcement is a standard corporate disclosure that helps the market prepare for the next major update on the company's performance. The stock is currently trading near its 52-week high, reflecting strong recent momentum ahead of this scheduled event.